Company Email Format Management

Rallybio

Biotechnology Research 234 Church Street 33 employees RLYB

Employees: 33
Contacts: 3
Emails: 3
Phones: 2

rallybio.com LinkedIn Crunchbase

Rallybio Overview

Headquarters: 234 Church Street
Phone Number: Available in AeroLeads
Website: rallybio.com
Industry: Biotechnology Research
Employees: 33
Founded: 2018
Stock Symbol: RLYB
Funding: 6.6M
Company Email: Available in AeroLeads
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

Rare Disease

About Rallybio

Rallybio (NASDAQ: RLYB) is a clinical-stage biotechnology company with a mission to develop and commercialize life-transforming therapies for patients with severe and rare diseases. Rallybio has built a pipeline of promising product candidates aimed at addressing diseases with unmet medical need in areas of complement dysregulation, hematology, and metabolic disorders. The Company’s lead program, RLYB116, is a differentiated C5 inhibitor with the potential to treat diseases of complement dysregulation. Rallybio also has two programs in preclinical development, including REV102, an ENPP1 inhibitor for the treatment of patients with hypophosphatasia (HPP), and RLYB332, a long-acting matriptase-2 antibody for the treatment of diseases of iron overload. Rallybio is headquartered in New Haven, Connecticut.

Rallybio Contact Details

People in AeroLeads: 4
With contact data: 3
Email contacts: 3; 75.0% coverage
Phone contacts: 2; 50.0% coverage

Rallybio Org Chart

Sample employees and titles

Name	Title	Location	Contact
Hui Liu	Biotech Builder, Deal Maker, Value	Greater Boston, United States	Email
Paula Soteropoulos	Board Chairman, Biotech CEO Founder	Greater Boston, United States	Email Phone
Tim R. Kendall (ティムケンダル)	Founder at Connektia. Bd&l Consultant		View
Kush Parmar, M.d., Ph.d.	Managing Partner at 5am Ventures	Boston, Massachusetts, United States	Email Phone